Concepedia
Statistics
Publications
9
Citations
863
H-Index
Active since
2009
Affiliations
Janssen (United States)(Current)
Johnson & Johnson (United States)
Springhouse
Genmab (Netherlands)
Kristen Chevalier is an author at Janssen (United States) specializing in medicine, immunology, and pharmacotherapy.
Top concepts
MedicineImmunologyPharmacologyDrug DiscoveryPharmacotherapyOncologyLung CancerBiochemistryCell BiologyTumor Biology
Publications per year
2009–2021
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors
Sheri L. Moores, Mark L. Chiu, Barbara S. Bushey et al. · Cancer Research · 2016 · 262 citations
Cmet Is Effective, Medicine, Receptor Tyrosine Kinase +15
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis
Smruthi Vijayaraghavan, Lorraine Lipfert, Kristen Chevalier et al. · Molecular Cancer Therapeutics · 2020 · 190 citations · Full text
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
Joost Neijssen, Rosa M. F. Cardoso, Kristen Chevalier et al. · Journal of Biological Chemistry · 2021 · 156 citations · Full text
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
PR Wade, JM Palmer, Sandra McKenney et al. · British Journal of Pharmacology · 2012 · 118 citations · Full text
Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity
John D. Douglass, Yin Zhou, Amy Wu et al. · Journal of Lipid Research · 2015 · 60 citations · Full text
1–5 of 9